Results 21 to 30 of about 2,449,966 (235)

The Severity of Bone Loss: A Comparison Between Cushing’s Disease and Cushing’s Syndrome

open access: yesJournal of Endocrinology and Metabolism, 2023
Background: This study aimed to estimate the prevalence of osteoporosis among patients with adrenal Cushing’s syndrome (ACS) and Cushing’s disease (CD), to investigate whether there is a difference in the degree of osteoporosis between both groups; and ...
Rania Naguib   +2 more
semanticscholar   +1 more source

Cardiovascular features of possible autonomous cortisol secretion in patients with adrenal incidentalomas [PDF]

open access: yes, 2018
Background: Low-grade incomplete post-dexamethasone cortisol suppression in patients with adrenal incidentalomas – recently defined as possible autonomous cortisol secretion (pACS) – has been associated with increased cardiovascular events and mortality.
Di Giorgio, Maria Rosaria   +12 more
core   +2 more sources

Endocrine hypertension - Cushing′s syndrome

open access: yesIndian Journal of Endocrinology and Metabolism, 2011
Hypertension is a major and frequent comorbid finding of Cushing′s syndrome. This review discusses the etiology and pathophysiology of hypertension in Cushing′s syndrome, while suggesting methods of management of this condition.
Yashpal Singh   +2 more
doaj   +1 more source

An open-label phase Ⅰ/Ⅱ a clinical trial of 11β-HSD1 inhibitor for Cushing's syndrome and autonomous cortisol secretion.

open access: yesJournal of Clinical Endocrinology and Metabolism, 2021
CONTEXT 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitors demonstrate anti-metabolic and anti-sarcopenic effects in Cushing's syndrome (CS) and autonomous cortisol secretion (ACS) patients.
S. Oda   +13 more
semanticscholar   +1 more source

A rare presentation of adrenal adenoma in infancy: isolated Cushing`s syndrome

open access: yesThe Turkish Journal of Pediatrics, 2020
Adrenocortical tumors are rare in children. Most of these tumors present with endocrinological manifestations, majority of which with virilizing features alone or in combination with over production of other adrenal hormones.
Oğuzhan Şal   +2 more
doaj   +1 more source

Iatrogenic Cushing′s syndrome after topical steroid therapy for psoriasis

open access: yesIndian Journal of Dermatology, 2016
Glucocorticoids are used for the treatment of many diseases, such as inflammatory, allergic, autoimmune, and neoplastic diseases. They can be used in the form of topical, oral, inhalable, rectal, and intra-articular agents.
Birsen Sahip   +7 more
doaj   +1 more source

Medullary thyroid cancer with ectopic Cushing's syndrome: A multicentre case series

open access: yesClinical Endocrinology, 2021
Ectopic Cushing′s syndrome (ECS) induced by medullary thyroid cancer (MTC) is rare, and data on clinical characteristics, treatment and outcome are limited.
V. Koehler   +11 more
semanticscholar   +1 more source

Renal function and morphology in aged Beagle dogs before and after hydrocortisone administration [PDF]

open access: yes, 2012
Objectives of this study were to evaluate glomerular filtration rate (GFR), renal structural changes and proteinuria in aged Beagle dogs before and after hydrocortisone (HC) administration.
Smets, Pascale   +7 more
core   +2 more sources

THU621 Mifepristone In Exogenous Cushing's Syndrome

open access: yesJournal of the Endocrine Society, 2023
Disclosure: S. Priyadarshan: None. D.O. Blavo: None. Introduction: Cushing’s syndrome is characterized by elevated cortisol levels in the body and is associated with significant morbidity and mortality.
Swetha Priyadarshan, Delali Ohui Blavo
semanticscholar   +1 more source

Monro-Kellie 2.0: The dynamic vascular and venous pathophysiological components of intracranial pressure [PDF]

open access: yes, 2016
For 200 years, the ‘closed box’ analogy of intracranial pressure (ICP) has underpinned neurosurgery and neuro-critical care. Cushing conceptualised the Monro-Kellie doctrine stating that a change in blood, brain or CSF volume resulted in reciprocal ...
Wilson, MH
core   +1 more source

Home - About - Disclaimer - Privacy